Calliditas Therapeutics AB (publ)
CLTEF · OTC
5/31/2025 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$977 | -$466 | -$40 | -$55 |
| Dep. & Amort. | $272 | $17 | $1 | $1 |
| Deferred Tax | $0 | $0 | $6 | -$1 |
| Stock-Based Comp. | $0 | $53 | $3 | $2 |
| Change in WC | $0 | -$80 | -$9 | -$1 |
| Other Non-Cash | $704 | $42 | -$273 | -$407 |
| Operating Cash Flow | -$1,099 | -$435 | -$30 | -$51 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$13 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$1 | -$5 | -$24 |
| Investing Cash Flow | $0 | -$14 | -$5 | -$24 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $6 | $226 | $482 | $194 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$6 | -$27 | $94 | $241 |
| Financing Cash Flow | $0 | $200 | $576 | $435 |
| Forex Effect | -$0 | -$27 | $34 | $10 |
| Net Chg. in Cash | $0 | -$275 | $14 | -$41 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $1,249 | $106 | $121 |
| End Cash | $0 | $974 | $120 | $106 |
| Free Cash Flow | -$1,099 | -$447 | -$30 | -$52 |